Home › Endometrial Cancer › Illinois › Aurora
Endometrial Cancer clinical trials in Aurora, IL
3 studies for Endometrial Cancer are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Northwestern Medicine Cancer Center Delnor, Geneva · 9 mi away
- Northwestern Medicine Cancer Center Kishwaukee, DeKalb · 25 mi away
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville · 11 mi away
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Other studies in Aurora
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- Prostate Cancer9 studies
- Melanoma7 studies
- Breast Cancer7 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Ovarian Cancer5 studies
- Cancer (all types)4 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
- Oral Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.